Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-ncov reverse transcriptase PCR assay for the detection of sars-cov-2
Detection Principle
NucleicAcid-PCR based
Target
N gene(LDT test); N, RdRP (ACOV); RdRP (IDNOW)
Testing Method Category
PCR_KIT
Testing Method
kit & in house
Testing Method - Additional Info
2 commercial molecular amplification assays (RealTime SARS-CoV-2 on the m2000 [abbreviated ACOV; Abbott] and ID Now COVID-19 [abbreviated IDNOW; Abbott]) and a laboratory-developed test (modified CDC 2019-nCoV reverse transcriptase PCR [RT-PCR] assay
Reported Performance
overall agreement: 83.5%; PPA: 75.2%-100%; NPA: 92.4%-100%
Sample Size
200 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements